MedTrace Logo

Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation

NCT02294097 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-11-19

No results posted yet for this study

Summary

The risk-benefit of surveillance-protocol biopsy (SPBx) in kidney transplantation remains unclear. The study aims to compare outcomes of recipients with SPBx approach to recipients with standard approach which allograft biopsy was performed only when indicated.

Conditions

  • Surveillance Protocol Biopsy

Interventions

PROCEDURE

Surveillance protocol kidney allograft biopsy

Surveillance protocol biopsy under ultrasound-guided will perform at post-operative day 7, month 3, month 6, month 12, and month 24

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Wiwat Chancharoenthana, MD.,MSc. · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02294097 on ClinicalTrials.gov